セルベースアッセイの世界市場2016-2026

◆英語タイトル:Cell-Based Assays World Industry and Market Prospects 2016-2026
◆商品コード:VGAIN60621
◆発行会社(調査会社):visiongain
◆発行日:2016年5月
◆ページ数:185
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Sigle User(1名利用)GBP1,999 ⇒換算¥283,858見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥425,858見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥709,858見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、セルベースアッセイの世界市場について調査・分析し、以下の構成でお届けいたします。
1. レポート概要

2. セルベースアッセイと応用の概要

3. セルベースアッセイの世界市場 2016-2026

4. 主要国のセルベースアッセイ市場 2016-2026

5. セルベースアッセイ市場における主要企業: 製品供給企業 2016

6. セルベースアッセイ市場における主要企業: CROとサービス提供企業 2016

7. セルベースアッセイ技術の動向および展望

8. セルベースアッセイ市場の定性分析 2016

9. 調査インタビュー

10. 研究・分析の結論
【レポートの概要】

Cell assaying for pharma – prospects for technologies shaping that medical testing
Visiongain’s new report, Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research, examines those companies, trends, products, services and technologies. It investigates how those forces will shape that bioassays industry over the next ten years. To support that analysis with data, our study shows revenue forecasts at overall world, submarket and national level. Its purpose is to help companies and other organisations understand the potential of that cellular testing for medicine.

Use of cell lines in bioassays becomes more important in drug discovery and development. The cost of developing a new drug is now estimated to be around $2.6bn. Set against that background of rising costs, cell-based assays have become a vital tool for drug discovery, development and basic research. Those assays provide many advantages over traditional biochemical assays and animal models, and are continuing to improve owing to advances in high-throughput screening (HTS) technology, automation and miniaturisation. Cell-based assays can provide a more-accurate representation of human in vivo conditions; they are reliable and, most important for drug development companies, they have high efficiency.

Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research

Increasing prominence of technologies such as microfluidics, label-free systems, 3D cell-based assays and IPSC cell lines will stimulate revenue growth in the cellular testing market from 2015. As with any other market, it holds challenges. These include high initial set-up costs, high complexity, need for skilled staff to run and analyse tests, and long developmental times for new products. However, visiongain predicts the cell-based assays market will grow strongly from 2016 to 2026, presenting many opportunities for assay product developers and suppliers, large CROs and specialist service providers, as well as many benefits for pharmaceutical companies.

Our work segments that bioassaying industry and market into two broad categories, with revenue forecasts to 2026 and discussions:
• Products
• Services

We also divide that medical testing industry into three main applications, again with sales forecasting:
• Drug discovery uses
• ADME (absorption, distribution, metabolism, excretion) testing
• Basic research purposes

Besides forecasting revenues for the previous submarkets, our study also breaks its overall world market prediction into these 11 leading national markets, to 2026:
• United States (US)
• Japan
• Germany, United Kingdom (UK), France, Spain, Italy (EU5 countries)
• Brazil, Russia, India, China (BRIC nations)

And here lie technologies and trends we cover, among others, showing how they shape that worldwide market to 2026:
• Stem cells (including IPSCs) for bioassays
• 3D cell-based systems
• Cell-based assaying for toxicity testing
• Increased outsourcing for that cellular screening
• Label-free technology
• GPCRs (G-protein-coupled receptors)
• Miniaturisation and automation
• Microfluidics and multiplexing
• High-content screening (HCS)
• Cell lines for pharma in vitro assays
• Cellular tests for the development of biologics (biological drugs)

Our 185 page report provides 48 tables and 66 figures covering different market segments categorized by application: drug discovery, ADME, and basic research; as well as by sector: products and services.

Moreover, 11 individual national markets are covered in addition to 20 leading companies which sell products and provide services.

Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research, published in May 2016, adds to visiongain’s range of reports on industries and markets in healthcare. Its portfolio includes studies on pharmaceuticals, medical devices, diagnostic tests and outsourced services, including contract researchers, manufacturers and sellers.

Ways Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research helps:
In particular, our new investigation gives you this knowledge to benefit your research, analyses and planning:
• Revenues for cellular assays, to 2026, at world level and for five submarkets – explore the prospects for design, production, sales, marketing, demand and spending
• Forecasts, to 2026, for 11 countries in the Americas, Europe and Asia – assess the developed and developing national markets for demand and predicted revenues
• Prospects for established firms, rising companies and new entrants – examine the product and service portfolios, results, strategies and outlooks for success
• Analyses of what stimulates and restrains that industry’s participants – investigate the challenges, strengths and competition affecting organisations’ actions
• Interviews with authorities in that field – discover what participants from the industry think, say and do, helping you stay ahead in business knowledge.

Information found nowhere else, benefiting your insight, work and influence
Our study, produced in-house by our UK-based analysts, provides independent knowledge. You will gain competitive intelligence found only in our report, finding where the progress and business prospects exist.

With our definitive market data you’re less likely to fall behind in information or miss an opportunity. See how you could save time and effort. And, through your choice, benefit your plans, decisions and authority, helping you gain competitive advantages.

Data to help your knowledge of pharma R&D – benefit from our study now
Our new analysis is for everyone investigating pharmaceutical research and development. For cellular assaying systems, you can explore the trends, results and revenue forecasts. So avoid missing out – please get that report here now.

【レポートの目次】

1. Report Overview
1.1 Cell-Based Assays Overview
1.2 Cell-Based Assays Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research Methods and Analysis
1.8 Frequently Asked Questions
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to Cell-Based Assays and Applications
2.1 Cost of New Drug Discovery and Development Reaches $2.6bn – Companies Constantly Looking for Increased Efficiencies
2.2 Drug Discovery Approaches – Target-Based and Phenotype-Based Discovery
2.3 Drug Screening Assays
2.4 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
2.5 Biochemical Assays and their Advantages over Animal Models
2.5.1 Applications of Biochemical Assays
2.5.2 Lead Identification and Toxicity Testing
2.6 Cell-Based Assays and their Advantages
2.7 2D vs 3D Cell-Based Assays
2.8 Advanced Cell-Based Assays
2.9 The Different Assay Detection Methods and Technologies
2.10 Cells used in Cell-Based Assays
2.10.1 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cell Lines
2.10.2 Primary Cells: Closer to the In Vivo Environment
2.10.3 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
2.11 Uses for Cell-Based Assays in Drug Discovery and Development
2.11.1 Target Validation
2.11.2 Primary Screening
2.11.3 Secondary Screening
2.11.4 ADME Screening
2.11.5 High Throughput Screening: Greatly Increases Efficiency

3. World Cell-Based Assays Market 2016-2026
3.1 Global Cell-Based Assays Market Forecast 2016-2026
3.2 Drivers for the Cell-Based Assays Market
3.3 Restraints for the Cell-Based Assays Market
3.4 Cell-Based Assays: Market Segments – Products and Services
3.5 Cell-Based Assays, Market Segments: Products Forecast 2016-2026
3.5.1 The Four Main Categories of Cell-Based Assay Products
3.5.1.1 Equipment Needed to Conduct Cell-Based Assays
3.5.1.2 Disposables Necessary to Perform Cell-Based Assays
3.5.1.3 Consumables Forming the Basis of Cell-Based Assays
3.5.1.4 Biobanks
3.6 Cell-Based Assays Market Segments: Services
3.6.1 Cell-Based Assays Market Segments: Services Forecast 2016-2026
3.7 Cell-Based Assays Market: Applications Forecasts 2016-2026
3.7.1 Drug Discovery Segment
3.7.2 ADME (Absorption, Distribution, Metabolism, Excretion) Segment
3.7.3 Basic Research Segment

4. Leading National Markets for Cell-Based Assays, 2016-2026
4.1 Regional Breakdown of the Global Cell-Based Assays Market, 2016-2026
4.2 Global Cell-Based Assays market: Regional Forecast 2016-2026
4.3 The US Cell-Based Assays Revenue Forecast 2016-2026
4.4 European Union (EU) Cell-Based Assays Market 2016-2026
4.4.1 IMI’s Pan-European Drug Discovery Platform holds Much Promise
4.4.2 EU National Market Share Breakdown, 2015, 2020 and 2026
4.4.3 EU Market: Main National Forecasts, 2016-2026
4.4.4 German Cell-Based Assay Revenue Forecast, 2016-2026
4.4.5 French Cell-Based Assays Revenue Forecast, 2016-2026
4.4.6 UK Cell-Based Assays Revenue Forecast, 2016-2026
4.4.7 Spanish Cell-Based Assays Revenue Forecast, 2016-2026
4.4.8 Italian Cell-Based Assays Revenue Forecast, 2016-2026
4.5 Japanese Cell-Based Assays Revenue Forecast, 2016-2026
4.6 BRIC Nations (Brazil, Russia, India and China) Cell-Based Assays Market
4.6.1 BRIC Countries National Breakdown, 2015, 2020 and 2026
4.6.2 BRIC Countries National Forecasts, 2016-2026
4.6.3 Chinese Cell-Based assay Revenue Forecast, 2016-2026
4.6.4 Indian Cell-Based Assays Revenue Forecast, 2016-2026
4.6.5 Russian Cell-Based Assays Revenue Forecast, 2016-2026
4.6.6 Brazilian Cell-Based Assays Revenue Forecast, 2016-2026

5. Leading Companies in the Cell-Based Assays Market: Product Suppliers, 2016
5.1 Thermo Fisher Scientific
5.1.1 ThermoFisher Scientific Financial Figures
5.1.2 Recent Developments at ThermoFisher Scientific
5.1.2.1 ThermoFisher Acquires Affymetrix
5.1.3 Cell-Based Assay Technologies under ThermoFisher’s Life Science Solutions Segment
5.2 DiscoveRx
5.2.1 DiscoveRx Assay Platforms and Technology
5.3 PerkinElmer
5.3.1 AlphaScreen Technology
5.3.2 DELFIA TRF Assays
5.3.3 Label-Free Cellular Assay Detection/Opera System
5.4 BD (Becton, Dickinson and Company)
5.4.1 Cell-Based Assays Through BD Life Sciences
5.5 InSphero
5.5.1 GravityPLUS – Leading Solution for 3D Cell-Based Assays
5.6 QGel
5.6.1 QGel Products and Services
5.7 Biocroi
5.7.1 Happy Cell ASM and its 3D Cell Culture
5.8 GE Healthcare
5.8.1 Cell-Based Assays Through GE Healthcare Life Sciences
5.9 Molecular Devices
5.9.1 Cell-Based Assay Products Include SpectraMax Microplate Readers and FLIPR Tetra System
5.10 Promega
5.10.1 Assays Range from Cell Viability Assays to Mitochondrial Function Assays
5.11 BioVision
5.11.1 Cell-Based Assays Include the EZCell Platform and a Cholesterol Detection Kit

6. Leading Companies in the Cell-Based Assays Market: CROs and Service Providers, 2016
6.1 Porsolt: Acquires Fluofarma
6.1.1 Fluofarma
6.1.2 Fluofarma has Over 100 Cell-Based Assays
6.2 CYTOO
6.2.1 Cell Micropatterning to Eliminate Trade-off Between Quantity and Quality?
6.2.2 Cell-Based Assays for Muscular Atrophy/Hypertrophy and Anti-Cancer Drug Profiling
6.3 Cell Assay Innovations (CAI)
6.3.1 ClariCELL Technology
6.4 ProQinase
6.4.1 ProQinase Cell-Based Assay Services, 2016
6.5 Charles River Laboratories
6.5.1 PhenoFocus – Portfolio of over 100 Primary Cell-Based Assays
6.6 BioAgilytix
6.7 SGS
6.7.1 Offers a Range of Services, Including 3D Cell-Based Assays
6.8 Pharmaceutical Product Development
6.9 Marin Biologic Laboratories

7. Cell-Based Assays Technology, Trends and Future Outlook
7.1 Stem Cells: Vast Potential
7.1.1 The Benefits of Using Stem Cells in Cell-Based Assays
7.1.2 iPSCs: An Uncontroversial and Abundant Source
7.1.3 Companies Providing Stem Cell-Based Assays
7.2 Toxicity Testing: Important Field for Cell-Based Assays
7.3 3D Systems: The Advantages of Next Generation of Cell Systems
7.3.1 Complexity of 3D Systems is a Challenge but More are Reaching the Market
7.3.2 Organoids – The Future of Drug Development?
7.3.2.1 Hurdles to the Future Organoid Market
7.3.2.2 Organoids Now and in the Future
7.3.3 Bio-Printing for Drug Development: Using 3D Printing Technology
7.4 Increasing Outsourcing of Cell-Based Assays
7.5 Label-Free Technology
7.6 GPCRs: A Common Drug and Drug Discovery Target
7.6.1 GPCRs in Cell-Based Assays
7.6.2 Allosteric GPCRs
7.7 Increasing Miniaturisation and Automation
7.7.1 Advantages of Miniaturisation
7.7.2 Advantages of Automation
7.8 Microfluids are Set to be a Trend
7.8.1 The Potential Challenges to Microfluids
7.9 Multiplexing: Improves Efficiency of cell-Based Assays
7.9.1 Advantages will Drive Growth
7.10 High Content Screening: A Well Established Tool
7.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
7.11 Cell-Based Assays for the Development of Biologics

8. Qualitative Analysis of the Cell-Based Assays Market, 2016
8.1 SWOT Analysis of the Cell-Based Assays Market
8.1.1 Strengths Within the Cell-Based Assay Market
8.1.2 Weaknesses Within the Cell-Based Assays Market
8.1.3 Opportunities for the Cell-Based Assays Market
8.1.4 Threats to the Cell-Based Assays Market
8.2 STEP Analysis of the Cell-Based Assays Market
8.2.1 Social Factors
8.2.2 Technological Factors
8.2.3 Economic Factors
8.2.4 Political Factors

9. Research Interviews
9.1 Interview with Dr Colin Sanctuary, CEO of QGel
9.1.1 On the Definition of Cell-Based Assays
9.1.2 On QGel Company Background and QGel Offerings
9.1.3 On the Cell-Based Assay Market Now and in the Future
9.1.4 On the Challenges to Cell-Based Assays and the Cell-Based Assay Market
9.1.5 On Considerations to Take when Purchasing Cell-Based Assays

10. Conclusions from the Research and Analysis
10.1 Growth Has Been Driven by Advantages of Cell-Based Assays
10.2 Current Status of the Market and its Growth Drivers
10.3 The Most Dominant National Markets and Emerging Countries
10.4 Future Trends and Technology

Table 1.1 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2016-2026
Table 2.1 Main Parameters Required in Drug Discovery and Development
Table 2.2 Selected Label-Free Detection Technologies Used for Cell-Based Assays, 2016
Table 2.3 Cell-Based Assays for HTS in Drug Screening, 2016
Table 3.1 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2026
Table 3.2 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2026
Table 3.3 Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2016-2026
Table 3.4 Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 3.5 Cell-Based Assays Market Application Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 3.6 Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2016-2026
Table 3.7 ADME Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 3.8 Basic Research Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2015
Table 4.2 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020
Table 4.3 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2026
Table 4.4 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2016-2026
Table 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%),Market Shares (%), CAGR (%), 2016-2026
Table 4.6 EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), World Market Shares (%), CAGR (%), 2016-2026
Table 4.7 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2015
Table 4.8 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2020
Table 4.9 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2026
Table 4.10 EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%),Market Share (%), CAGR (%), 2016-2026
Table 4.11 German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.12 French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.13 UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.14 Spanish Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Table 4.15 Italian Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Table 4.16 Japanese Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Table 4.17 BRIC Countries Breakdown by Nation: BRIC market Shares (%), Global Market Shares (%) and Revenues ($m), 2015
Table 4.18 BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2020
Table 4.19 BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2026
Table 4.20 BRIC National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.21 Chinese National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.22 Indian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.23 Russian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 4.24 Brazilian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 5.1 ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 5.2 Life Technologies Cell-Based Assay Technology Overview, 2016
Table 5.3 Life Technologies Cell-Based Assay Technology Overview, 2016
Table 5.4 Other DiscoveRx Assay Platforms, 2016
Table 5.5 PerkinElmer Revenue Breakdown: Revenue ($m) for Fiscal Year Ending 3rd January 2016
Table 5.6 QGel Products and Services Cell-Based Assay Products, 2016
Table 5.7 GE Healthcare Life Sciences Cell-Based Assay Products, 2016
Table 6.1 ProQinase Cell-Based Assay Services, 2016
Table 6.2 Charles River Laboratories Revenue Breakdown: Revenue ($m), 2013-2015
Table 6.3 Cell-Based Assay Platforms, Details and Benefits Used by BioAgilytix , 2016
Table 7.1 Selected Companies with Involvement in Stem Cell-Based Assays, 2016
Table 7.2 Selected Companies Offering Label-Free Assay Systems, 2016

Figure 1.1 Cell-Based Assays Market Segmented by Application
Figure 1.2 Cell-Based Assays Market Segmented by Sector
Figure 1.3 Cell-Based Assays Products Market Segments
Figure 2.1 Stages of Pre-Clinical Drug Development
Figure 3.1 Global Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
Figure 3.2 Drivers and Restraints for the Cell-Based Assays Market, 2016
Figure 3.3 Cell-Based Assays Market Segments Forecasts: Revenue ($m), 2016-2026
Figure 3.4 Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), 2016-2026
Figure 3.5 Cell-Based Assays Market Segments: Products Forecast - AGR (%), 2016-2026
Figure 3.6 Cell-Based Assay Products Overview, 2016
Figure 3.7 Cell-Based Assays Market Segments: Services Forecast - Revenue ($m), 2016-2026
Figure 3.8 Cell-Based Assays Market Segments: Services Forecast – AGR (%), 2016-2026
Figure 3.9 Cell-Based Assays Market Application Forecasts: Revenue ($m), 2016-2026
Figure 3.10 Drug Discovery Segment Forecast: Revenue ($m), 2016-2026
Figure 3.11 Drug Discovery Segment Forecast: AGR (%), 2016-2026
Figure 3.12 ADME Segment Forecast: Revenue ($m), 2016-2026
Figure 3.13 ADME Segment Forecast: AGR (%), 2016-2026
Figure 3.14 Basic Research Segment Forecast: Revenue ($m), 2016-2026
Figure 3.15 Basic Research Segment Forecast: AGR (%), 2016-2026
Figure 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2015
Figure 4.2 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020
Figure 4.3 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2026
Figure 4.4 Global Cell-Based Assays Market, Regional Forecasts: Revenues ($m), 2016-2026
Figure 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Figure 4.6 US Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.7 EU Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Figure 4.8 EU Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.9 EU Market Breakdown by Nation: EU Market Shares (%), 2015
Figure 4.10 EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2020
Figure 4.11 EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2026
Figure 4.12 EU Market, Top National Forecasts: Revenue ($m), 2016-2026
Figure 4.13 German Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Figure 4.14 German Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.15 French Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Figure 4.16 French Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.17 UK Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
Figure 4.18 UK Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.19 Spanish Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.20 Spanish Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.21 Italian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.22 Italian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.23 Japanese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.24 Japanese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.25 BRIC Countries Breakdown by Nation: Market Shares (%), 2015
Figure 4.26 BRIC Countries Breakdown by Nation: Market Shares (%), 2020
Figure 4.27 BRIC Countries Breakdown by Nation: Market Shares (%), 2026
Figure 4.28 BRIC Countries Breakdown by Nation: Revenues ($m), 2016-2026
Figure 4.29 Chinese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.30 Chinese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.31 Indian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
Figure 4.32 Indian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.33 Russian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
Figure 4.34 Russian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 4.35 Brazilian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
Figure 4.36 Brazilian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
Figure 5.1 ThermoFisher Scientific Historical Sales: Revenue ($m), 2010-2015
Figure 5.2 PerkinElmer Revenue Breakdown: Revenue ($m) for Fiscal Year Ending 3rd January 2016
Figure 5.3 BD Revenue Breakdown: Revenue ($m), 2015
Figure 6.1 Charles River Laboratories Revenue Breakdown: Revenue ($m), 2013-2015
Figure 8.1 Strengths and Weaknesses of the Cell-Based Assay Market, 2016
Figure 8.2 Strengths and Weaknesses of the Cell-Based Assay Market, 2016
Figure 9.1 Projected growth from 2000-2025 with and without a solution for industrialisation of advanced 3D cell-based assays.
Figure 9.2 Proportion of Types of Cell Based Assay Used n 2014 and Predicted in 2024
Figure 10.1 The Cell-Based Assay Submarket Revenue ($m) Breakdown by Products and Services, 2015, 2020 and 2026
Figure 10.2 The Cell-Based Assay Submarket Revenue ($m) Breakdown by Application: Drug Discovery, ADME and Basic Research, 2015, 2020 and 2026
Figure 10.3 Regional Breakdown of the Cell-Based Assay Market by Revenue ($m), 2015, 2020 and 2026

★調査レポート[セルベースアッセイの世界市場2016-2026]販売に関する免責事項
★調査レポート[セルベースアッセイの世界市場2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆